Q2 2018

Filed Aug 20, 2018 · 10-Q · 51 days after period end · 0001654954-18-009398

Q2 2018 · 10-Q

Revenue

$0.00

— vs Q2 2017

Net Income

-$559.71K

N/M vs Q2 2017

EPS Diluted

-$0.12

N/M vs Q2 2017

Gross Profit$0—

Operating Income

Same quarter

Metric	Q2 2018	Q2 2017	Q2 2016	Q2 2015
Revenue	$0.00	$0.00	$0.00	$0.00
Net Income	-$559.71K	-$506.30K	-$260.87K	-$112.63K
EPS Diluted	-$0.12	-$0.02	-$0.03	-$0.22

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Panacea Life Sciences Holdings, Inc. · CIK 1552189 · Engraved from SEC EDGAR